Plasma Protein Therapeutics Association (PPTA)
Home
About PPTA
Monography
Core SPC
Links
Newsletters
Search
Contact
Hepatology
#
Article Title
1
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials.
2
Diagnosis and therapy of ascites in liver cirrhosis.
3
Role of artificial liver support in hepatic encephalopathy.
4
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
5
Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome.
6
[Comparative study of hospital costs associated with human albumin 20% (Vialebex((R)) 20%) or polyge
7
Prevention and treatment of infections in patients with cirrhosis.
8
Diagnosis and treatment of acute renal failure in patients with cirrhosis.
9
[Renal dysfunction after spontaneous bacterial peritonitis in cirrhosis: incidence and risk factors.
10
New treatments of hepatorenal syndrome.
11
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded ra
12
The management of severe alcoholic liver disease and variceal bleeding in the intensive care unit.
13
Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furose
14
Effects of artificial liver support system on patients with acute or chronic liver failure.
15
Hepatorenal syndrome
16
A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacte
17
Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with sp
18
Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for tr
19
Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
20
Albumin: Biochemical properties and therapeutic potential.
21
Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure.
22
The use of albumin in patients with decompensated cirrhosis: the case in favor.
23
Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
24
[Advances in Therapy for Ascites and Hepatorenal Syndrome.]
25
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainmen
<<
Start
<
Prev
1
2
3
Next
>
End
>>
Page 1 of 3
Literature database
Alzheimer
ARDS/ALI
Ascites
Burns
Cardiac surgery
Hepatology
Hypo-albuminaemia
Hypo-volemia
Kidney/Liver transplant
Albumin Dialysis
Nephrotic Syndrome
Neurology/Stroke
Other indications
OHSS
Plasma exchange
Safety profile
Sepsis
Systematic Review
Malaria
Get your personal copy here >>